{"product_id":"9781461361183","title":"Developments in Oncology: Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991","description":"\u003ch1\u003eDevelopments in Oncology: Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991\u003c\/h1\u003e \u003ch2\u003eValeriote, Frederick A.; Corbett, Thomas H.; Baker, Laurence H.\u003c\/h2\u003e \u003cp\u003eWith the publication of these proceedings from the Second Drug  Discovery and Development Symposium, this forum has become the main  mechanism for bringing together the principal groups involved in both  discovering and developing new approaches to the treatment of cancer.  This Second Symposium emphasized the types of materials being  discovered and their therapeutic activity. This is especially evident  in the natural product discovery programs, where unique and active  structures are being identified. \u003cbr\u003e  The major contributors to the meeting were the investigators  participating in the National Cooperative (Natural Products) Drug  Discovery Groups [NC(NP)DDG]. These groups reflect an association  among researchers at universities or cancer centers, pharmaceutical  companies and the National Cancer Institute. Their sources of  materials are varied, reflecting chemical inventories of  pharmaceutical companies, organic synthetic compounds from the  laboratory, cytotoxics as well as biologics and their hybrids, and  natural products obtained from plants, marine organisms and  microorganisms. The models employed in the discovery systems vary from  broadly cellular based to specific enzymes to defined cellular  functions. Each of them is believed important to the malignant state  and will allow for the discovery of compounds which will have efficacy  in cancer therapy. \u003cbr\u003e  The goal of the participants is both to discover new anticancer agents  and to develop them as efficiently as possible into clinically useful  additions to treatment. Of importance is the fact that there are a  number of promising leads which will soon be moving into the clinic  thereby testing the effectiveness of this NC (NP) DDG approach. \u003cbr\u003e\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2012-10-08\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9781461361183\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-1-4615-2610-0\u003c\/p\u003e \u003cp\u003eDimensions: 235cm x155cm\u003c\/p\u003e \u003cp\u003ePages: 403\u003c\/p\u003e ","brand":"Springer US","offers":[{"title":"Default Title","offer_id":44398582071436,"sku":"9781461361183","price":296.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781461361183.jpg?v=1771516163","url":"https:\/\/lateknightbooks.com\/products\/9781461361183","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}